Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

TORONTO--(BUSINESS WIRE)--Conscience, a non-profit focused on accelerating drug discovery in areas of unmet medical need using open science and radical collaboration, is pleased to announce three ...

Evan Feinberg founded Genesis Molecular AI seven years ago to take his research at Stanford on AI for drug discovery to the real world. Today the company announced its biggest partnership to date: A ...

AI is increasingly used to accelerate and improve drug discovery and development. AI tools, like AlphaFold and autonomous labs, help identify targets and process massive datasets. Regulatory standards ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development. Under the new ...

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

Daraxonrasib doubled median survival versus chemotherapy in metastatic pancreatic cancer phase 3 trial. Uses novel partner-protein strategy to target previously "undruggable" RAS oncogene effectively.

One year ago this week, Baby KJ received his very first infusion of a gene therapy made specifically for him. 1 He had a unique mutation that led to carbamoyl-phosphate synthetase 1 (CPS1) deficiency, ...